Transversalis Fascia Plane Block Versus Erector Spinae Plane Block for Analgesia in Inguinal Hernia Repair

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05565365
Collaborator
(none)
60
2
13

Study Details

Study Description

Brief Summary

Uncontrolled postoperative pain after inguinal hernia repair increases the incidence of postoperative complications.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Transversalis fascia plane (TFP) block
  • Procedure: Erector Spinae Plane (ESP) Block
N/A

Detailed Description

Inguinal hernia repair is one of the most common surgical procedures in the world. Annually, more than 20 million inguinal hernia repairs are conducted worldwide.

Uncontrolled postoperative pain increases the incidence of postoperative complications. Regional blocks, as a part of multimodal analgesia, can improve pain control in the postoperative period and reduce complications that may arise from using a single mode of analgesia. For example, reliance on opioid analgesia increases the incidence of pruritus, nausea, and vomiting, as well as respiratory depression.

Hebbard first described the ultrasound (US)-guided transversalis fascia plane (TFP) block in 2009. A local anesthetic (LA) injected between the transversus abdominis muscle and its deep investing fascia will block the anterior and the lateral branches of the T12 and L1 nerves.

Erector spinae plane block (ESPB) is a type of facial plane block in which local anesthetic is administered in the plane located between the erector spinae muscle and thoracic transverse process. ESPB blocks the transmission of nociceptive stimuli through the dorsal/ventral rami of the spinal nerve roots, prevents afferent stimuli transmission, and inhibits efferent activation of the sympathetic nervous system and can thus provide both somatic and visceral sensory blockade, which would make it an ideal regional anesthetic technique for abdominal surgery.The effect of ESPB is also achieved through the block of the lateral, posterior, and anterior thoracic wall resulting in multiple levels sensory blocks. Additional proposed mechanism of action could be explained by the epidural spread of the anesthetics.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Ultrasound-guided Transversalis Fascia Plane Block Versus Erector Spinae Plane Block for Post-operative Analgesia in Inguinal Hernia Repair Under General Anesthesia: a Randomized Controlled Study
Anticipated Study Start Date :
Nov 14, 2022
Anticipated Primary Completion Date :
Dec 15, 2023
Anticipated Study Completion Date :
Dec 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Transversalis fascia plane (TFP) block

Patients will receive unilateral US-TFP block with bupivacaine 15 minutes before skin incision

Procedure: Transversalis fascia plane (TFP) block
Patients will receive unilateral US-TFP block with 0.3 mL/kg bupivacaine 0.25% 15 minutes before skin incision
Other Names:
  • TFP block
  • Active Comparator: Erector Spinae Plane (ESP) Block

    Patients will receive unilateral US-ESP block with bupivacaine 15 minutes before skin incision

    Procedure: Erector Spinae Plane (ESP) Block
    Patients will receive unilateral US-ESP block with 0.3 mL/kg bupivacaine 0.25% 15 minutes before skin incision
    Other Names:
  • ESP Block
  • Outcome Measures

    Primary Outcome Measures

    1. The intensity of postoperative pain [24 hours after surgery]

      Assessed by the verbal analog pain scale graded from 0 to 10 (0 = no pain, and 10 = the worst possible pain)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 65 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Male patients undergoing elective open unilateral inguinal hernia repair under general anesthesia, ASA status I-II, aged from 20 to 65 years old
    Exclusion Criteria:
    • Contraindications to regional block (coagulopathy, infection at the needle insertion site, or diaphragmatic paralysis)

    • Altered cognitive function

    • Body mass index (BMI > 35 kg/m2)

    • Patients who have difficulty understanding the study protocol

    • Patients who have any known allergy to study medications

    • Advanced hepatic or renal failure

    • Chronic opioid consumption

    • Patient refusal

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Assiut University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Seham Mohamed Moeen Ibrahim, Assistant professor of Anesthesia and Intensive Care, Assiut University
    ClinicalTrials.gov Identifier:
    NCT05565365
    Other Study ID Numbers:
    • SM 10 2022
    First Posted:
    Oct 4, 2022
    Last Update Posted:
    Oct 4, 2022
    Last Verified:
    Sep 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 4, 2022